Global X China Biotech Innovation ETF (CHB)
CHB is a passive ETF by Global X tracking the investment results of the Solactive China Biotech Innovation Index. CHB launched on Sep 22, 2020 and has a 0.67% expense ratio.
ETF Info
| ISIN | US37954Y2515 |
|---|---|
| CUSIP | 37954Y251 |
| Issuer | Global X |
| Inception Date | Sep 22, 2020 |
| Region | Global ex-U.S. (Broad) |
| Category | Innovation, China Equities, Health & Biotech Equities |
| Index Tracked | Solactive China Biotech Innovation Index |
| Home Page | www.globalxetfs.com |
| Asset Class | Equity |
Asset Class Size | Multi-Cap |
Asset Class Style | Blend |
Expense Ratio
The Global X China Biotech Innovation ETF has a high expense ratio of 0.67%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Global X China Biotech Innovation ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | N/A | 5.29% |
| 1 month | N/A | -2.47% |
| 6 months | N/A | 16.40% |
| 1 year | N/A | 20.88% |
| 5 years (annualized) | N/A | 11.60% |
| 10 years (annualized) | N/A | 10.43% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -17.10% | |||||||||||
| 2023 | 2.79% | 6.22% | 5.23% | -4.12% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Global X China Biotech Innovation ETF (CHB) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Global X China Biotech Innovation ETF granted a 101.85% dividend yield in the last twelve months. The annual payout for that period amounted to $6.76 per share.
| Period | TTM | 2023 | 2022 |
|---|---|---|---|
| Dividend | $6.76 | $0.04 | $0.02 |
Dividend yield | 101.85% | 0.48% | 0.21% |
Monthly Dividends
The table displays the monthly dividend distributions for Global X China Biotech Innovation ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | |||||||||||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.02 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Global X China Biotech Innovation ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Global X China Biotech Innovation ETF was 66.72%, occurring on Feb 5, 2024. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -66.72% | Feb 17, 2021 | 733 | Feb 5, 2024 | — | — | — |
| -10.8% | Oct 14, 2020 | 42 | Dec 11, 2020 | 15 | Jan 5, 2021 | 57 |
| -6.83% | Jan 26, 2021 | 4 | Jan 29, 2021 | 3 | Feb 3, 2021 | 7 |
| -1.74% | Jan 11, 2021 | 1 | Jan 11, 2021 | 1 | Jan 12, 2021 | 2 |
| -0.89% | Jan 13, 2021 | 1 | Jan 13, 2021 | 1 | Jan 14, 2021 | 2 |
Volatility
Volatility Chart
The current Global X China Biotech Innovation ETF volatility is 4.49%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.